(Q38190349)

30 August 2017

1 reference

title

The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis (English)

1 reference

30 August 2017

0 references

2

Tanuja Chitnis

1 reference

30 August 2017

Riley Bove

1

1 reference

30 August 2017

publication date

21 February 2014

1 reference

Multiple Sclerosis Journal

30 August 2017

published in

1 reference

30 August 2017

volume

20

1 reference

30 August 2017

issue

5

1 reference

30 August 2017

page(s)

520-526

1 reference

Geographical variations in sex ratio trends over time in multiple sclerosis.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Clustering of autoimmune disease in families at high risk for multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Sex-specific environmental influences affecting MS development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Body size and risk of MS in two cohorts of US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Association between comorbidity and clinical characteristics of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Correlations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Differential effects of genetic susceptibility factors in males and females with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Low serum urate levels are associated to female gender in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Sexual disparities in the incidence and course of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

The effect of gender in clinically isolated syndrome (CIS): a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Risk factors for and management of cognitive dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Gender differences in MRI studies on multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Gender effects on intramuscular interferon beta-1a in relapsing–remitting multiple sclerosis: analysis of 1406 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Glatiramer acetate treatment in PPMS: why males appear to respond favorably.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Estrogen and testosterone therapies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Role of puberty in multiple sclerosis risk and course

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Rising incidence of multiple sclerosis in females associated with urbanization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Treatment of multiple sclerosis with the pregnancy hormone estriol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Long-term effects of childbirth in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Reproduction and the risk of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Effects of pregnancy and breastfeeding on the multiple sclerosis disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Oral contraceptives and the risk of multiple sclerosis: a review of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Autoimmune diseases and reproductive aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Effect of gender on late-onset multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Male menopause: is it a real clinical syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Sex hormones modulate brain damage in multiple sclerosis: MRI evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Testosterone treatment in multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

Relapses in multiple sclerosis are age- and time-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513519181

21 January 2018

Identifiers

DOI

10.1177/1352458513519181

1 reference

30 August 2017

1 reference